The DePuy hip replacement recall is the latest defective product recall coming from pharmaceutical giant, Johnson & Johnson. The number of recalls from J&J has been increasing with 40 products being recalled due to manufacturing defects and hazardous risk factors in April 2010 alone. The response from J&J to these recalls has been dubious and should be a clear indicator of what to expect for those involved in a hip replacement lawsuit.
Although J&J CEO William Weldon made a public apology before Congress in September of 2010 for “letting the public down”, these conciliatory words were just an attempt to mask the practices of the company to prevent any more recalled products from coming to light. While a public admission has been made about poorly manufacturing equipment and contaminated drugs causing these recalls, the company has been reluctant in revealing its practices of managing the recall of its potentially harmful drugs and products. Apparently, management of previously recalled products, specifically the defective non-steroidal anti-inflammatory drug Motrin, has been to prevent revealing to the public the need for its recall by hiring contractors to buy bottles off shelves nationwide, also known as “phantom recalls”.
Government organizations such as the House Committee on Oversight and Government Reform as well as the Principal Deputy Commissioner of the U.S. Food and Drug Administration have questioned the ethical nature of the “phantom recall”, sighting impropriety on the part of J&J. The company remained silent about accusations that it told these contractors to dress as regular customers while removing potentially dangerous products that J&J knew was contaminated.
The amount of deception on the part of DePuy’s parent company in conjunction with the lack of sufficient quality control is quite disturbing. While seeming apologetic on the surface, underneath is the company’s attitude towards disregarding the health and safety of its clients and a desire to avoid having more defective products undergo a public recall. It should not be surprising that J&J and DePuy are encouraging victims of the hip replacement recall to sign over their legal rights in exchange for payoffs that would be substantially less than those that may be awarded by a jury.
It is for these reasons that those affected by the DePuy recall should be aware of J&J’s former recall practices and get the consult of an experienced attorney handling hip replacement lawsuits. For more information regarding ongoing litigation, visit the DePuy hip replacement lawsuit website.


